Secondly, neither the CALR exon 9 mutant load (typically ~50%) nor the variable JAK2V617F mutant load correlate with the blood parameters of patients, when JAK2V617F-mutated PV and ET patients are studied separately. This evidence concerns the gene CALR and essential thrombocythemia.